Bladder cancer: the value of routine bone scintigraphy.
Two hundred and twenty-one patients with invasive bladder cancer had routine bone scintigraphy performed as part of tumour staging. The incidence of detectable metastases was 12%. Skeletal scintigraphy at diagnosis has a sensitivity of only 38%. The predictive value of a negative examination was 92%. These results suggest that skeletal scintigraphy is not indicated as a routine staging procedure in carcinoma of the bladder.
D000368:Aged; D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary; D002294:Carcinoma, Squamous Cell / Q000000981:diagnostic imaging* / Q000556:secondary; D002295:Carcinoma, Transitional Cell / Q000000981:diagnostic imaging* / Q000556:secondary; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D001749:Urinary Bladder Neoplasms / Q000000981:diagnostic imaging*